What to Expect on NAD+: Week by Week Timeline

IV NAD+ infusions are commonly associated with a surge in mental clarity and physical energy during or shortly after the infusion. Some individuals experience transient chest tightness, nausea, or flushing during the drip, which is typically managed by adjusting the infusion rate. The immediate boost is often described as a feeling of the brain and body being switched on to a higher gear.

Subcutaneous users typically report the first signs of improved energy and mental clarity within the first week. Post-IV, the enhanced energy often sustains for several days before gradually tapering. Sleep quality improvements are commonly reported early in both administration routes.

Sustained subcutaneous use over two to four weeks is commonly associated with progressively improving mitochondrial function. Many users describe a stable baseline of higher energy rather than the peaks and valleys of the initial adjustment period. Brain fog reduction and improved exercise tolerance are frequently cited during this window.

By months two to three, many people describe a comprehensive improvement in physical and cognitive performance. Skin quality and overall appearance improvements are sometimes reported, attributed to NAD+'s role in DNA repair and sirtuin activation. Lab work may reveal improvements in markers of oxidative stress and metabolic efficiency.

Long-term NAD+ support is commonly structured as periodic IV boosts combined with ongoing subcutaneous maintenance. Many providers recommend regular lab monitoring to track NAD+ and related metabolites over time. The longevity-oriented benefits are best assessed over extended periods with consistent tracking of biological age markers.